Articles Tagged With: Neurology
-
Few Severe Stroke Patients Receive Palliative Care
Severe stroke can be similarly devastating as cancer — not only for the patient, but for family members caring for that patient. They all may need symptom relief and emotional support that palliative care can provide.
-
Neurologists Add Nuance to Palliative Care Definition
Position paper authors underscore the importance of care goals discussions with patients and families throughout the disease course, not just at end of life.
-
Neurology Groups Update Position on Stroke and Informed Consent
Experts provide updated ethical guidance on decision-making capacity, emergency treatment, and clinical research.
-
Clinicians’ Confusion over Brain Death Criteria Persists
There are inconsistencies between standards and institutional protocols and clinical practice. Inconsistencies can erode clinician and public trust in the determination of death by neurologic criteria. Inconsistencies also can cause false-positive determinations in which a patient is incorrectly determined to be dead. Ethicists should advocate for ensuring clinicians involved in the determination of death by neurologic criteria are equipped with appropriate expertise.
-
The Passing of M. Flint Beal, MD
A tribute to the late M. Flint Beal, MD. -
Defense Ruling on Appeal for Radiologist Who Reviewed and Reported Imaging Results
This case demonstrates both procedural and substantive defenses for physicians and care providers. For the procedural side, the reversal by the appellate court reveals defendants in malpractice cases need not always wait for a jury to determine the care provider did not act negligently. -
Undiagnosed Brain Tumor Results in Permanent Brain Damage, $3.35 Million Award
In this case, the physician’s liability was a case of failure to diagnose, a particularly concerning result given the physician’s treatment of the patient over the course of more than four years. A failure to diagnose, or a delayed diagnosis, can cause significant injuries or dramatically worsen the patient’s condition. -
Long-Term Effects of Cholinesterase Inhibitors on Cognitive Decline, Mortality
Cholinesterase inhibitors are one of the few drug classes approved by the FDA to treat patients with Alzheimer’s disease. This study shows a long-term benefit in slowing the decline of cognition, but it is unclear if there is any benefit in quality of life. -
Researchers Observe No Connections Between Statin Therapy, Cognitive Decline
But randomized trials are needed to better detail long-term risk-benefit ratio. -
Aducanumab-avwa Injection (Aduhelm)
The FDA has approved a new, but controversial, treatment for Alzheimer’s disease.